An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
Guian Zhang,1 Yong Luo2 1School of Medicine, South China University of Technology, Guangzhou, 510006, People’s Republic of China; 2Department of Urology, the Second People’s Hospital of Foshan, Affiliated Foshan Hospital of Southern Medical University, Foshan, 528000, People’s Republic of ChinaCorre...
Guardado en:
Autores principales: | Zhang G, Luo Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c1b9ff2d73b140fab8d844a993e271e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
por: Ke Wang, et al.
Publicado: (2021) -
Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Xing Zhou, et al.
Publicado: (2022) -
Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma
por: Li FW, et al.
Publicado: (2021) -
Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021) -
Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
por: Pan J, et al.
Publicado: (2019)